These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 15175666)

  • 61. US and biologists wary of strict biotech rules.
    Cyranoski D
    Nature; 2004 Mar; 428(6978):6. PubMed ID: 14999250
    [No Abstract]   [Full Text] [Related]  

  • 62. Food labeling update: FDA and USDA release proposed regulations.
    J Am Diet Assoc; 1991 Dec; 91(12):1514. PubMed ID: 1960339
    [No Abstract]   [Full Text] [Related]  

  • 63. Growing pains.
    Nature; 2011 Jul; 475(7356):265-6. PubMed ID: 21776037
    [No Abstract]   [Full Text] [Related]  

  • 64. Market watch.
    Macilwain C
    Nature; 2006 Dec; 444(7121):805. PubMed ID: 17167447
    [No Abstract]   [Full Text] [Related]  

  • 65. Beyond food and evil.
    Chen J
    Duke Law J; 2007 Apr; 56(6):1581-6. PubMed ID: 17679180
    [No Abstract]   [Full Text] [Related]  

  • 66. Consumer protection from an EU regulation on the mandatory labelling of genetically modified food.
    Clin Lab; 2004; 50(5-6):380-1. PubMed ID: 15209444
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Politics holds back animal engineers.
    Maxmen A
    Nature; 2012 Oct; 490(7420):318-9. PubMed ID: 23075955
    [No Abstract]   [Full Text] [Related]  

  • 68. United States government regulations affecting aspergilli and their products.
    Schechtman MG
    Biotechnology; 1992; 23():271-96. PubMed ID: 1504602
    [No Abstract]   [Full Text] [Related]  

  • 69. Consumers and GM food: a divergent relation.
    Verdurme A
    Meded Rijksuniv Gent Fak Landbouwkd Toegep Biol Wet; 2001; 66(4):335-9. PubMed ID: 15954315
    [No Abstract]   [Full Text] [Related]  

  • 70. Biotechnology and the food label: a legal perspective.
    Degnan FH
    Food Drug Law J; 2000; 55(3):301-10. PubMed ID: 11824462
    [No Abstract]   [Full Text] [Related]  

  • 71. Risk assessment. End of an era.
    Anderson C
    Nature; 1991 Sep; 353(6342):289. PubMed ID: 1922329
    [No Abstract]   [Full Text] [Related]  

  • 72. Putting Cartagena into practice.
    Watanabe KN; Taeb M; Okusu H
    Nat Biotechnol; 2004 Oct; 22(10):1207-8. PubMed ID: 15470448
    [No Abstract]   [Full Text] [Related]  

  • 73. Tougher rules aim to prevent gene flow into crops.
    Hoag H
    Nature; 2003 Mar; 422(6928):103. PubMed ID: 12634744
    [No Abstract]   [Full Text] [Related]  

  • 74. Social and legal determinants for the marketing of GM products in Poland.
    Twardowski T; Małyska A
    N Biotechnol; 2012 Feb; 29(3):249-54. PubMed ID: 22210291
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The real curse of Frankenfood.
    Miller HI
    Nat Biotechnol; 1999 Feb; 17(2):113. PubMed ID: 10052332
    [No Abstract]   [Full Text] [Related]  

  • 76. Nanotech under scrutiny, but tighter regulation remains distant.
    Kling J
    Nat Biotechnol; 2007 Oct; 25(10):1068. PubMed ID: 17921977
    [No Abstract]   [Full Text] [Related]  

  • 77. Transgenic salmon nears approval.
    Ledford H
    Nature; 2013 May; 497(7447):17-8. PubMed ID: 23636372
    [No Abstract]   [Full Text] [Related]  

  • 78. Roger Beachy. Interview by Emily Waltz.
    Beachy R
    Nat Biotechnol; 2010 Jan; 28(1):11-2. PubMed ID: 20062028
    [No Abstract]   [Full Text] [Related]  

  • 79. Biotechnology: US Congress right to halt GM salmon.
    Kimbrell A; O'Neil C
    Nature; 2011 Aug; 476(7360):283. PubMed ID: 21850093
    [No Abstract]   [Full Text] [Related]  

  • 80. Will we reap what biopharming sows?
    Miller HI
    Nat Biotechnol; 2003 May; 21(5):480-1. PubMed ID: 12721561
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.